GLA
ANGO icon

Great Lakes Advisors’s AngioDynamics ANGO Stock Holding History

Great Lakes Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-104,861
Closed -$2.33M – 601
2018
Q2 		$2.33M Sell
104,861
-156,255
-60% -$3.19M 0.05% 299
2018
Q1 		$4.5M Sell
261,116
-1,127
-0.4% -$18.8K 0.11% 189
2017
Q4 		$4.36M Sell
262,243
-19,121
-7% -$326K 0.1% 186
2017
Q3 		$4.81M Buy
281,364
+64,877
+30% +$1.09M 0.11% 158
2017
Q2 		$3.51M Buy
+216,487
New +$3.42M 0.09% 202

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Great Lakes Advisors's ANGO Position: Q3 2018 in Review

Great Lakes Advisors sold out of AngioDynamics (ANGO) in Q3 2018, closing a stake of 104,861 shares — an estimated $2.33M sold.

Great Lakes Advisors first reported a position in ANGO in Q2 2017 and held it in 5 quarters. The position peaked at $4.81M in Q3 2017. 177 funds tracked by Wall St. Rank hold ANGO as of Q3 2018.

  • Great Lakes Advisors reported no remaining AngioDynamics position as of Q3 2018 after selling out during the quarter.
  • Great Lakes Advisors sold 104,861 AngioDynamics shares in Q3 2018, an estimated $2.33M.
  • Great Lakes Advisors first reported a position in AngioDynamics in Q2 2017 and held it in 5 quarters.
  • Great Lakes Advisors's AngioDynamics position peaked at $4.81M in Q3 2017.
  • 177 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2018.

Based on Great Lakes Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.